Vacunas antimeningocócicas. Situación epidemiológica mundial y estrategias de prevención mediante la vacunación

Rivero Calle, Irene; Rodriguez-Tenreiro Sánchez, Carmen; Martinón-Torres, Federico.
Enferm. infecc. microbiol. clín. (Ed. impr.) ; 33(4): 257-267, abr. 2015. ilus, tab, mapas, graf
Artículo en Español | IBECS (España) | ID: ibc-136741

Documentos relacionados

  1. Inference of transmission dynamics and retrospective forecast of invasive meningococcal disease.
  2. Characterisation of Neisseria meningitidis cc11/ET-15 variant by whole genome sequencing.
  3. Pediatric Invasive Meningococcal Disease, Auckland, New Zealand (Aotearoa), 2004-2020.
  4. Carriage prevalence of Neisseria meningitidis in China, 2005-2022: a systematic review and meta-analysis.
  5. Impact of Meningococcal ACWY Vaccination Program during 2017-18 Epidemic, Western Australia, Australia.
  6. Comprehensive Genome Analysis of <i>Neisseria meningitidis</i> from South America Reveals a Distinctive Pathogenicity-Related Prophage Repertoire.
  7. Analysis of meningococcal vaccine uptake in patients with invasive meningococcal disease, Czech Republic, 2006-2022.
  8. Effectiveness of Meningococcal Vaccines at Reducing Invasive Meningococcal Disease and Pharyngeal Neisseria meningitidis Carriage: A Systematic Review and Meta-analysis.
  9. Reactive vaccination as control strategy for an outbreak of invasive meningococcal disease caused by <i>Neisseria meningitidis</i> C:P1.5-1,10-8:F3-6:ST-11(cc11), Bergamo province, Italy, December 2019 to January 2020.
  10. B Part of It School Leaver Study: A Repeat Cross-Sectional Study to Assess the Impact of Increasing Coverage With Meningococcal B (4CMenB) Vaccine on Carriage of Neisseria meningitidis.